About John Deacon
Form D filings for Cytosolix in 2023 list John Deacon as executive officer and director.
John Deacon first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name John Deacon in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Deacon works with at each company, as listed on that company's latest Form D.
Cytosolix, Inc. · Form D, Jun 28, 2023